For the quarter ended June 2025, Westlake Chemical (WLK) reported revenue of $2.95 billion, down 7.9% over the same period last year. EPS came in at -$0.09, compared to $2.40 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $3.04 billion, representing a surprise of -2.84%. The company delivered an EPS surprise of -250%, with the consensus EPS estimate being $0.06.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Westlake performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Westlake here>>>
Shares of Westlake have returned -3.1% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Sep-09 | |
| Aug-21 | |
| Aug-14 | |
| Aug-04 | |
| Aug-04 | |
| Aug-04 | |
| Aug-04 | |
| Aug-04 | |
| Jul-21 | |
| Jun-15 | |
| May-15 | |
| May-05 | |
| May-05 | |
| May-05 | |
| May-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite